期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肝癌患者血清p16甲基化检测 被引量：2

肝癌患者血清p16甲基化检测
原文传递
导出
作者 南克俊 魏永长 李春丽 隋晨光 阮之平 黄辰
机构地区 西安交通大学第一医院肿瘤内科 西安交通大学医学实验中心
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2004年第9期569-570,共2页 Chinese Journal of Oncology
基金 陕西省科技攻关资助项目 ( 2 0 0 2K10 G1)
关键词 血清 启动子区 肝癌患者 HCC CPG岛甲基化 P16基因 甲基化特异性PCR 核酸 分子机制 发现 Liver neoplasms Carcinoma,hepatocellular p16 Methylation Methylation-specific PCR
分类号 R735.7 [医药卫生—肿瘤] R730 [医药卫生—肿瘤]
  • 相关文献

参考文献1

二级参考文献8

  • 1Herman JG,Graff JR,Myohanen S,et al.Methylaiton-Specific PCR: a novel PCR assay for methylation status of CpG islands[].Proceedings of the National Academy of Sciences of the United States of America.1996
  • 2Jahr S,Hentze H,Englisch S,et al.DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells[].Cancer Research.2001
  • 3Anker P,Lefort F,Vasioukhin V,et al.K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer[].Gastroenterology.1997
  • 4Mulcahy HE,Lyautey J,Lederrey C,et al.A prospective study of K-ras mutations in the plasma of pancreatic cancer patients[].Clinical Cancer Research.1998
  • 5Wong IH,Lo YM,Zhang J,et al.Detection of aberrant p16 methylation in the plasma and serum of liver cancer pa-tients[].Cancer Research.1999
  • 6Silva JM,Dominguez G,Villanueva MJ,et al.Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients[].British Journal of Cancer.1999
  • 7Esteller M,Sanchez-Cespedes M,Rosell R, et al.Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients[].Cancer Research.1999
  • 8Sanchez-Cespedes M,Esteller M,Wu L,et al.Gene promoter hypermethylation in tumors and serum of head and neck cancer patients[].Cancer Research.2000

共引文献30

同被引文献20

  • 1刘建余,覃扬,孙芝琳,孙泽芳.人原发性肝癌中p16,p15基因CpG岛甲基化研究[J].四川大学学报（自然科学版）,2002,39(S1):127-132. 被引量：5
  • 2Di Vinci A, Perdelli L, Banelli B, et al. p16(INK4a) promoter methylation and protein expression in breast fibroadenoma and carcinoma. Int J Cancer, 2005, 114: 414-421.
  • 3Ranger GS, Jewell A, Thomas V, et al. Elevated expression of cyclooxygenase-2 in breast cancer and ductal carcinoma in situ has no correlation with established prognostic markers. J Surg Oncol, 2004,88: 100-103.
  • 4Denkert C, Winzer KJ, Hauptmann S. Prognostic impact of cyclooxygenase-2 in breast cancer. Clin Breast Cancer, 2004, 4:428-433.
  • 5Ristimaki A, Sivula A, Lundin J, et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res,2002, 62: 632-635.
  • 6Davies G, Salter J, Hills M, et al. Conelation between cyclooxygenase-2 expression and angiogenesis in human breast cancer. Clin Cancer Res, 2003, 9: 2651-2656.
  • 7Half E, Tang XM, Gwyn K, et al. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res, 2002, 62: 1676-1681.
  • 8Stott FJ,Bates S,James MC,et al.The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2[].EMBO Journal.1998
  • 9Tao W,Levine A J.P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2[].Proceedings of the National Academy of Sciences of the United States of America.1999
  • 10Esteller M,Cordon-Cardo C,Corn PG,et al.p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2[].Cancer Research.2001

引证文献2

二级引证文献7

中华肿瘤杂志
2004年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部